Key statistics
On Wednesday, Kyverna Therapeutics Inc (KYTX:NSQ) closed at 4.12, 4.57% above its 52-week low of 3.94, set on Nov 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.20 |
---|---|
High | 4.34 |
Low | 4.05 |
Bid | 4.01 |
Offer | 6.50 |
Previous close | 4.08 |
Average volume | 282.66k |
---|---|
Shares outstanding | 43.15m |
Free float | 38.49m |
P/E (TTM) | -- |
Market cap | 177.77m USD |
EPS (TTM) | -2.50 USD |
Data delayed at least 15 minutes, as of Nov 20 2024 21:00 GMT.
More ▼
- Kyverna Therapeutics Announces New Patient Data Highlighting Potential of KYV-101 for Treatment of Lupus Nephritis in Symposium at ACR Convergence 2024
- Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
- Kyverna Therapeutics Appoints Mert Aktar to its Board of Directors
- Kyverna Therapeutics Presents Patient Data Reinforcing Potential of KYV-101 for Treatment of Neuroinflammatory Diseases in Symposium at ECTRIMS 2024
- Kyverna Therapeutics Announces Leadership Update
More ▼